Agência Brasília Teste do pezinho ampliado em mais de 500 mil recém-nascidos. 27 de setembro de 2021. Available from: https://www.agenciabrasilia.df.gov.br/2021/09/27/teste-do-pezinho-ampliado-para-meio-milhao-de-recem-nascidos/

Bardakjian TM, Klapper J, Carey A et al (2019) Addressing the Value of Multidisciplinary Clinical Care in Huntington’s Disease: a snapshot of a New Huntington’s Disease Center. J Huntingtons Dis 8(4):501–507. https://doi.org/10.3233/JHD-190355

Article  PubMed  Google Scholar 

Brasil Distrito Federal. Lei nº 4.190, de 06 de agosto de 2008. Disponível em: https://www.jusbrasil.com.br/legislacao/2821851812/lei-4190-08-df

Brasil Presidência da República. Lei Nº 14.154 de 26 de Maio de 2021

Brasil (2020) Ministério da Saúde. Secretaria de Atenção Especializada à Saúde, Secretaria de Ciência, Tecnologia e Insumos Estratégicos em Saúde. Protocolo para o Diagnóstico Etiológico da Deficiência Intelectual

Brasil. Ministério da Saúde. Portaria No 199, de 30 de janeiro de 2014 (2014) Available from: https://bvsms.saude.gov.br/bvs/saudelegis/gm/2014/prt0199_30_01_2014.html

Brazilian Rare Disease Portal (RARASBR) (2020) https://doi.org/10.25504/FAIRsharing.d7b6c8

Camelo Junior JS, Saunders C, Castilhos CB, Giugliani R (2011) Newborn screening for galactosemia: a health economics evaluation. Cad Saude Publica 27(4):666–676. https://doi.org/10.1590/S0102-311X2011000400008

Article  PubMed  Google Scholar 

Cardoso-Dos-Santos AC, Magalhães VS, Medeiros-de-Souza AC, Bremm JM, Alves RFS, Araujo VEM et al (2020) International collaboration networks for the surveillance of congenital anomalies: a narrative review. Epidemiol Serv Saude 29(4). https://doi.org/10.5123/S1679-49742020000400009

Chung CCY, Hong Kong Genome Project, Chu ATW, Chung BHY (2022) Rare disease emerging as a global public health priority. Front Public Health 10:1028545. https://doi.org/10.3389/fpubh.2022.1028545

Article  PubMed  PubMed Central  Google Scholar 

Coelho AVC, Mascaro-Cordeiro B, Lucon DR, Nóbrega MS, Reis RS, de Alexandre RB et al (2022) The Brazilian rare genomes project: validation of whole genome sequencing for Rare diseases diagnosis. Front Mol Biosci 9:821582. https://doi.org/10.3389/fmolb.2022.821582

Article  PubMed  PubMed Central  Google Scholar 

DATASUS (2024) http://tabnet.datasus.gov.br/. Accessed 23 Mar

de Oliveira BM, Bernardi FA, Baiochi JF et al (2024) Epidemiological characterization of rare diseases in Brazil: a retrospective study of the Brazilian rare diseases Network. Orphanet J Rare Dis 19(1):405. https://doi.org/10.1186/s13023-024-03392-7

Article  PubMed  PubMed Central  Google Scholar 

de Souza IP, Androlage JS, Bellato R, Barsaglini R (2019) Rare genetic diseases with qualitative approach: Integrational review of national and international literature. Cienc Saude Colet 24(10):3651–3663

Google Scholar 

Dharssi S, Wong-Rieger D, Harold M, Terry S (2017) Review of 11 national policies for rare diseases in the context of key patient needs. Orphanet J Rare Dis 12(1):63. https://doi.org/10.1186/s13023-017-0618-0

Article  PubMed  PubMed Central  Google Scholar 

Félix TM, de Oliveira BM, Artifon M et al (2022) Epidemiology of rare diseases in Brazil: protocol of the Brazilian rare diseases Network (RARAS-BRDN). Orphanet J Rare Dis 17:84. https://doi.org/10.1186/s13023-022-02254-4

Article  PubMed  PubMed Central  Google Scholar 

Félix TM, Oliveira BMd, Horovitz DDG (2024) Building a National Policy for Rare Disease in Brazil. J Community Genet. https://doi.org/10.1007/s12687-024-00732-9

Article  PubMed  Google Scholar 

Gahl WA, Mulvihill JJ, Toro C et al (2016) The NIH Undiagnosed Diseases Program and Network: applications to modern medicine. Mol Genet Metab 117(4):393–400. https://doi.org/10.1016/j.ymgme.2016.01.007

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giugliani R, Vairo FP, Riegel M, de Souza CF, Schwartz IV, Pena SD (2016) Rare disease landscape in Brazil: report of a successful experience in inborn errors of metabolism. Orphanet J Rare Dis 11(1):76. https://doi.org/10.1186/s13023-016-0458-3

Article  PubMed  PubMed Central  Google Scholar 

Giugliani R, Bender F, Couto R, Bochernitsan A, Brusius-Facchin AC, Burin M et al (2019) Population medical genetics: translating science to the community. Genet Mol Biol 42(3 Suppl 1):312–320. https://doi.org/10.1590/1678-4685-GMB-2018-0019

Article  CAS  PubMed  PubMed Central  Google Scholar 

Horovitz DDG, de Faria Ferraz VE, Dain S, Marques-de-Faria AP (2013) Genetic services and testing in Brazil. J Community Genet 4(3):355–375. https://doi.org/10.1007/s12687-012-0096-y

Article  PubMed  Google Scholar 

Iriart JAB, Nucci MF, Muniz TP, Viana GB, Aureliano WA, Gibbon S (2019) From the search for diagnosis to treatment uncertainties: challenges of care for rare genetic diseases in Brazil. Cien Saude Colet 24(10):3637–3650

Article  PubMed  PubMed Central  Google Scholar 

Kanegae MPP, Barreiros LA, Sousa JL et al (2022) SCID and other inborn errors of immunity with low TRECs - the Brazilian experience. J Clin Immunol 42:1171–1192. https://doi.org/10.1007/s10875-022-01275-9

Article  CAS  PubMed  Google Scholar 

Kaufmann P, Pariser AR, Austin C (2018) From scientific discovery to treatments for rare diseases– the view from the National Center for Advancing Translational Sciences– Office of Rare diseases Research. Orphanet J Rare Dis 13:196. https://doi.org/10.1186/s13023-018-0936-x

Article  PubMed  PubMed Central  Google Scholar 

Kokkinou E, Roka K, Alexopoulos A et al (2019) Development of a multidisciplinary clinic of neurofibromatosis type 1 and other neurocutaneous disorders in Greece. A 3-year experience. Postgrad Med 131(7):445–452. https://doi.org/10.1080/00325481.2019.1659708

Article  PubMed  Google Scholar 

Kubaski F, Vairo F, Michelin-Tirelli K et al (2023) Pilot study of newborn screening for six lysosomal diseases in Brazil. Genet Mol Biol 46(3 Suppl 1). https://doi.org/10.1590/1678-4685-GMB-2023-0035

Lew RM, Burnett L, Proos AL, Barlow-Stewart K, Delatycki MB, Bankier A et al (2015) Ashkenazi jewish population screening for Tay-Sachs disease: the international and Australian experience. J Paediatr Child Health 51(3):271–279. https://doi.org/10.1111/jpc.12632

Article  PubMed  Google Scholar 

Lopes-Júnior LC, Ferraz VEF, Lima RAG, Schuab SIPC, Pessanha RM, Luz GS et al (2022) Health policies for Rare Disease patients: a scoping review. Int J Environ Res Public Health 19(22):15174. https://doi.org/10.3390/ijerph192215174

Article  PubMed  PubMed Central  Google Scholar 

Lopez-Bastida J, Oliva-Moreno J, Linertova R, Serrano-Aguilar P (2016) Social/economic costs and health-related quality of life in patients with rare diseases in Europe. Eur J Health Econ 17(1):1–5. https://doi.org/10.1007/s10198-016-0780-7

Article  PubMed  Google Scholar 

Mayrides M, Ruiz de Castilla EM, Szelepski S (2020) A civil society view of rare disease public policy in six latin American countries. Orphanet J Rare Dis 15(1):60. https://doi.org/10.1186/s13023-020-1314-z

Article  PubMed  PubMed Central  Google Scholar 

Melo DG, Sequeiros J (2012) The challenges of incorporating genetic testing in the unified national health system in Brazil. Genet Test Mol Biomarkers 16(7):651–655. https://doi.org/10.1089/gtmb.2011.0286

Article  PubMed  Google Scholar 

Netto ABO, Brusius-Facchin AC, Lemos JF, Pasetto FB, Brasil CS, Trapp FB, Saute JAM et al (2023) Neonatal screening for spinal muscular atrophy: a pilot study in Brazil. Genet Mol Biol 46(3 Suppl 1). https://doi.org/10.1590/1678-4685-GMB-2023-0126

Nguengang Wakap S, Lambert DM, Olry A, Rodwell C, Gueydan C, Lanneau V et al (2020) Estimating cumulative point prevalence of rare diseases: analysis of the Orphanet database. Eur J Hum Genet 28(2):165–173. https://doi.org/10.1038/s41431-019-0508-0

Article  PubMed  Google Scholar 

Oliveira BM, Neiva MB, Carvalho I, Schwartz IVD, Alves D, Felix TM et al (2023) Availability of Genetic Tests in Public Health Services in Brazil: data from the Brazilian rare diseases Network. Public Health Genomics 26(1):1. https://doi.org/10.1159/000531547

Article  Google Scholar 

Passos-Bueno MR, Bertola D, Horovitz DDG, de Faria Ferraz VE, Brito LA (2014) Genetics and genomics in Brazil: a promising future. Mol Genet Genomic Med 2(4):280–291. https://doi.org/10.1002/mgg3.78

Article  PubMed  PubMed Central  Google Scholar 

Poswar FO, da Silva LP, Zambrano MB, Pedrini DB, Saute JAM, Giugliani R (2021) Clinical trials for genetic diseases in Latin America. Am J Med Genet C Semin Med Genet 187(3):381–387. https://doi.org/10.1002/ajmg.c.31934

Article  PubMed  Google Scholar 

Reis LC, Sobrinho LMF, Tonon T, Acosta MB, Iopp GD, Faquetti L et al (2023) Estudo-piloto: das capacitações em UBS até a triagem neonatal ampliada para erros inatos do metabolismo por MS/MS. Anais do VIII Congresso Norte-Nordeste de Genética Médica; ISBN: 978-65-272-0274-5

Roberts AD, Wadhwa R (2024) Orphan Drug Approval Laws. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; Available from: https://www.ncbi.nlm.nih.gov/books/NBK572052/

Rosenberg AGW, Pater MRA, Pellikaan K et al (2021) What every internist-endocrinologist should know about Rare Genetic syndromes in Order to Prevent Needless Diagnostics, missed diagnoses and Medical complications: five years of ‘Internal Medicine for Rare Genetic syndromes’. J Clin Med 10(22):5457 Published 2021 Nov 22. https://doi.org/10.3390/jcm10225457

Article  CAS